BIOMARIN PHARMACEUTICAL INC Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 38.59 | 9,844 | 379,880 | 30,000 | |
| Jun 27 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 96.60 | 9,844 | 950,930 | 83,581 | 93.4 K to 83.6 K (-10.54 %) |
| Jun 27 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 38.59 | 9,844 | 379,880 | 93,425 | 83.6 K to 93.4 K (+11.78 %) |
| Jun 23 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 21.51 | 2,671 | 57,453 | 0 | |
| Jun 23 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 100.00 | 2,671 | 267,100 | 12,885 | 15.6 K to 12.9 K (-17.17 %) |
| Jun 23 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 21.51 | 2,671 | 57,453 | 15,556 | 12.9 K to 15.6 K (+20.73 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 603 | 22,588 | 47,331 | |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 9,397 | 352,012 | 47,934 | |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 5,000 | 132,450 | 15,225 | |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 603 | 54,270 | 136,422 | 137 K to 136.4 K (-0.44 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 603 | 22,588 | 137,025 | 136.4 K to 137 K (+0.44 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 9,397 | 845,730 | 136,422 | 145.8 K to 136.4 K (-6.44 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 5,000 | 450,000 | 145,819 | 150.8 K to 145.8 K (-3.32 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 9,397 | 352,012 | 150,819 | 141.4 K to 150.8 K (+6.64 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 5,000 | 132,450 | 141,422 | 136.4 K to 141.4 K (+3.67 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 11,250 | |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 90.00 | 3,750 | 337,500 | 15,910 | 19.7 K to 15.9 K (-19.07 %) |
| Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 19,660 | 15.9 K to 19.7 K (+23.57 %) |
| Jun 13 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 26.49 | 3,775 | 100,000 | 0 | |
| Jun 13 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 21.51 | 5,464 | 117,531 | 0 | |
| Jun 13 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 26.49 | 3,775 | 100,000 | 83,581 | 79.8 K to 83.6 K (+4.73 %) |
| Jun 13 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 21.51 | 5,464 | 117,531 | 79,806 | 74.3 K to 79.8 K (+7.35 %) |
| Jun 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 89.61 | 1,004 | 89,968 | 47,944 | 48.9 K to 47.9 K (-2.05 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 2,050 | 0 | 15,910 | 13.9 K to 15.9 K (+14.79 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 2,050 | 0 | 4,910 | 2.9 K to 4.9 K (+71.68 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 2,050 | 0 | 9,885 | 7.8 K to 9.9 K (+26.16 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,050 | 0 | 26,060 | 24 K to 26.1 K (+8.54 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 2,050 | 0 | 29,810 | 27.8 K to 29.8 K (+7.38 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 2,050 | 0 | 39,185 | 37.1 K to 39.2 K (+5.52 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 2,050 | 0 | 36,310 | 34.3 K to 36.3 K (+5.98 %) |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | Dere Willard H | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
| Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | Dere Willard H | Director | Grant | A | 0.00 | 2,050 | 0 | 4,690 | 2.6 K to 4.7 K (+77.65 %) |
| Jun 07 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 91.04 | 9,471 | 862,230 | 74,342 | 83.8 K to 74.3 K (-11.30 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 90.72 | 1,801 | 163,387 | 23,303 | 25.1 K to 23.3 K (-7.17 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Payment of Exercise | F | 90.72 | 376 | 34,111 | 12,885 | 13.3 K to 12.9 K (-2.84 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 90.72 | 2,036 | 184,706 | 136,422 | 138.5 K to 136.4 K (-1.47 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 90.72 | 1,488 | 134,991 | 48,948 | 50.4 K to 48.9 K (-2.95 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 90.72 | 1,644 | 149,144 | 144,583 | 146.2 K to 144.6 K (-1.12 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 90.72 | 1,488 | 134,991 | 83,813 | 85.3 K to 83.8 K (-1.74 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 0 | |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 5,000 | |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.56 | 5,000 | 452,800 | 226,924 | 231.9 K to 226.9 K (-2.16 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 231,924 | 226.9 K to 231.9 K (+2.20 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 90.72 | 6,640 | 602,381 | 226,924 | 233.6 K to 226.9 K (-2.84 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.70 | 5,000 | 448,500 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
| Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 10,000 | |
| Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.53 | 5,000 | 437,650 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
| Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
| Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 7,423 | 128,641 | 15,000 | |
| Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.29 | 7,423 | 655,377 | 233,564 | 241 K to 233.6 K (-3.08 %) |
| Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 7,423 | 128,641 | 240,987 | 233.6 K to 241 K (+3.18 %) |